These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 10376492)
1. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492 [TBL] [Abstract][Full Text] [Related]
2. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148 [TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of the use of femural percutaneous closure systems with simultaneous use of abciximab. Timóteo AT; Batista J; Almeida M; Machado FP; Palos JL; Silva JA; Seabra-Gomes R Rev Port Cardiol; 2003 Sep; 22(9):1063-72. PubMed ID: 14655309 [TBL] [Abstract][Full Text] [Related]
4. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Assali AR; Sdringola S; Moustapha A; Ghani M; Salloum J; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR Catheter Cardiovasc Interv; 2003 Jan; 58(1):1-5. PubMed ID: 12508187 [TBL] [Abstract][Full Text] [Related]
5. Vasoseal hemostasis following coronary interventions with abciximab. Lunney L; Karim K; Little T J Invasive Cardiol; 1999 Sep; 11 Suppl B():2B-3B. PubMed ID: 10745610 [TBL] [Abstract][Full Text] [Related]
6. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures. Kim HY; Choo SW; Roh HG; Han H; Kim SS; Lee JY; Park YR; Lee SH; Shin SW; Park KB; Do YS; Cho SK; Lee IH; Kim SM; Byun HS; Jeon P Korean J Radiol; 2006; 7(1):35-40. PubMed ID: 16549954 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Michalis LK; Rees MR; Patsouras D; Katsouras CS; Goudevenos J; Pappas S; Sourla E; Kolettis T; Sioros L; Zotou P; Gartzou-Matsouka P; Sideris DA Cardiovasc Intervent Radiol; 2002; 25(5):423-9. PubMed ID: 12132030 [TBL] [Abstract][Full Text] [Related]
9. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. Nikolsky E; Mehran R; Halkin A; Aymong ED; Mintz GS; Lasic Z; Negoita M; Fahy M; Krieger S; Moussa I; Moses JW; Stone GW; Leon MB; Pocock SJ; Dangas G J Am Coll Cardiol; 2004 Sep; 44(6):1200-9. PubMed ID: 15364320 [TBL] [Abstract][Full Text] [Related]
10. Vasoseal hemostasis following coronary interventions with Abciximab. Lunney L; Karim K; Little T Cathet Cardiovasc Diagn; 1998 Aug; 44(4):405-6. PubMed ID: 9716204 [TBL] [Abstract][Full Text] [Related]
11. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. Applegate RJ; Grabarczyk MA; Little WC; Craven T; Walkup M; Kahl FR; Braden GA; Rankin KM; Kutcher MA J Am Coll Cardiol; 2002 Jul; 40(1):78-83. PubMed ID: 12103259 [TBL] [Abstract][Full Text] [Related]